Velsera

About Velsera

This company provides a software platform that integrates multi-omics data with domain expertise and knowledge, transforming scientific and technological information into actionable insights. Their solution accelerates research and development in the healthcare and life science industries by making complex data more accessible and useful.

```xml <problem> The increasing volume and complexity of multi-omics data, combined with siloed information and a lack of standardization, hinders the efficient translation of research findings into clinical applications and slows down the development of precision medicine.</

What does Velsera do?

This company provides a software platform that integrates multi-omics data with domain expertise and knowledge, transforming scientific and technological information into actionable insights. Their solution accelerates research and development in the healthcare and life science industries by making complex data more accessible and useful.

Where is Velsera located?

Velsera is based in Boston, United States.

When was Velsera founded?

Velsera was founded in 2023.

Location
Boston, United States
Founded
2023
Employees
554 employees
Looking for specific startups?
Try our free semantic startup search

Velsera

Score: 100/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

This company provides a software platform that integrates multi-omics data with domain expertise and knowledge, transforming scientific and technological information into actionable insights. Their solution accelerates research and development in the healthcare and life science industries by making complex data more accessible and useful.

velsera.com10K+
Founded 2023Boston, United States

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (500+)

Aditya Phatak

Unknown

Company Description

```xml <problem> The increasing volume and complexity of multi-omics data, combined with siloed information and a lack of standardization, hinders the efficient translation of research findings into clinical applications and slows down the development of precision medicine.</

Velsera | StartupSeeker